Ida Bruun Kristensen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients (NCT04717700) | Ida Bruun Kristensen | 2021-08-18 |
Track Ida Bruun Kristensen automatically
Every clearance here is in the API, with alerts when new ones post.